Sharaxaada Alaabta
PEG-rhG-CSF ee duritaanka ) loogu talagalay bukaannada aan-miyeloablative malignancy iyadoo la daweynayo Antineoplastic, marka laga yaabo in ay leedahay muhiimadda bukaan-socod ee neutrophilic-ku-yaraynta myelosuppression, iyadoo la isticmaalayo alaabtan si loo yareeyo heerka dhacdooyinka caabuqa ee uu keeno qandho neutropenia. PEGylated Recombinant Human Granulocyte Colony ee Kicinta Cunsurka Durida Looma isticmaalo abaabulka unugga horraanta dhiigga ee durugsan ee tallaalka unugyada tarma ee hematopoietic.
Magaca daroogada
Magaca Guud. PEGylated Recombinant Human Granulocyte Colony ee Kicinta Cunsurka Durida
Magaca Ingiriisiga. PEGylated Recombinant Human Granulocyte Colony ee Kicinta Cunsurka Durida
PEGylated Recombinant Human Granulocyte Colony ee Kicinta Cunsurka Durida Sharaxaada
dareere cad
PEGylated Recombinant Human Granulocyte Colony ee Kicinta Cunsurka Durida Tilmaamaha
1. It is used for the patients of non-myeloablative malignancy with the treatment of antineoplastic, when may have clinic significance of febrile neutrophilic reduce myelosuppression, using this product to reduce the incidence rate of infection caused by febrile neutropenia.
2. Alaabtan looma isticmaalo abaabulka unugga horraanta dhiigga ee durugsan ee tallaalka unugyada tarma ee hematopoietic.
PEGylated Recombinant Human Granulocyte Colony ee Kicinta Cunsurka Durida Contraindication
Waa mamnuuc xasaasiyadda PEG-rhG-CSF,rhG-CSF iyo e.coli muujinta diyaargarowga kale.
Tilmaamid
3 mg/ml
Baakadaha
1 dhalo/sanduuq
Diyaargaraw
duritaan
